MAP3K12 and Gliosis: Although the elimination of DLK did not reduce Aβ42 production, plaque load, or alter tau pathology, DLK-knockout mice had higher levels of full-length amyloid precursor protein (APP), amyloid plaque, plaque-associated gliosis, and enhanced cell survival in the subiculum of tau [123].